Displaying 7 results for

On July 13, 2021, ASTHO issued a statement of support for President Joe Biden’s nomination of Rahul Gupta, MD, MPH, MBA, FACP, to serve as the Director of the Office of National Drug Control Policy.

On Sept. 29, 2021, Louisiana’s top public health official, and ASTHO member, Joseph M. Kanter, MD, MPH testified to the Select Subcommittee on the Coronavirus Crisis on the need to upgrade and strengthen public health infrastructure in the ...

On July 15, 2021, ASTHO CEO, Michael Fraser, PhD, issued a statement support for U.S. Surgeon General Vivek Murthy’s new advisory "Confronting Misinformation: The U.S. Surgeon General’s Advisory on Building a Healthy Information ...

ASTHO issued a statement of concern for public health and healthcare workers on June 25, 2021, following the publication of a CDC MMWR Early Release, that details the devastating effects of the COVID-19 pandemic

On April 29, 2021, ASTHO and its members announced support for FDA actions in advancing two tobacco product standards rulemaking processes to remove menthol as a characterizing flavor in cigarettes and removing all flavors including ...

On May 13, 2021, ASTHO CEO Michael Fraser issued a strong statement of support for the Biden administration's American Rescue Plan Act of 2021, which includes a large investment in public heath.

On March 11, 2021, ASTHO CEO Michael Fraser released a statement applauding Congress and the Biden administration on the passage of the American Rescue Plan Act of 2021.